
    
      This study aims to enroll 40 patients with mild and moderate Alzheimer's disease with apathy
      symptoms that will be randomized to receive rTMS or sham procedure. Subjects will be
      randomized in two arms (rTMS or sham procedure) in 1:1 proportion.

      Eligibility criteria:

        -  Diagnosis of Alzheimer's disease, mild and moderate stage (MMSE range from 10 to 20);

        -  Diagnosis of apathy;

        -  age between 60 and 85 years-old;

        -  On stable doses of cholinesterase inhibitors (donepezil, rivastigmine, galantamine) or
           memantine for at least 6 months prior to enrollment;

      The primary outcome measures is the Apathy Inventoire. Secondary outcome measures are the NPI
      score, ADAS-cog scores and the Zarit Burden Scale scores.
    
  